BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32695204)

  • 21. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
    Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
    Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison.
    Terheyden MM; Melchert C; Kovács G
    J Contemp Brachytherapy; 2016 Aug; 8(4):294-300. PubMed ID: 27648082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy.
    Takenaka T; Yamazaki H; Suzuki G; Masui K; Shimizu D; Kotsuma T; Tanaka E; Yoshida K; Yamada K
    J Contemp Brachytherapy; 2023 Jun; 15(3):191-197. PubMed ID: 37425205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study.
    Malde R; Agarwal JP; Laskar SG; Gupta T; Dinshaw K
    Bull Cancer; 2005 Jul; 92(7):E45-50. PubMed ID: 16122998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To analyze the impact of intracavitary brachytherapy as boost radiation after external beam radiotherapy in carcinoma of the external auditory canal and middle ear: a retrospective analysis.
    Badakh DK; Grover AH
    J Cancer Res Ther; 2014; 10(2):342-6. PubMed ID: 25022389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
    Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
    Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost.
    Wang CC
    Am J Clin Oncol; 1991 Feb; 14(1):5-8. PubMed ID: 1987739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
    Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients.
    Gao L; Xu GZ; Yin WB; Yan JH; Cai WM; Gu XZ
    Chin Med J (Engl); 1993 Jun; 106(6):467-70. PubMed ID: 8222900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
    Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
    Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.
    Murakami N; Kato T; Miyamoto Y; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Umezawa R; Inaba K; Ito Y; Igaki H; Itami J
    Anticancer Res; 2016 May; 36(5):2413-21. PubMed ID: 27127151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
    Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-guided high-dose-rate interstitial brachytherapy boost in the radical radiotherapy for a huge metastatic carcinoma of cervical lymph nodes from an unknown primary site.
    Wang M; Wu N; Han D; Zhao H; Cheng G
    Cancer Radiother; 2019 Sep; 23(5):426-431. PubMed ID: 31255579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.